Bangalore-based company Anthem Biosciences has raised ₹1,016.02 crore from 60 anchor investors ahead of its IPO.
The IPO was opened for anchor investors on 11th July. For retail investors, the IPO will open on 14th July and will close on 16th July.
The company informed on Friday that it has allotted 1.78 crore shares to anchor investors at the price of ₹570 per share.
IPO Details: Price Band, Lot Size, and Listing
The company has set the IPO price band at ₹540 to ₹570 per share. A lot of 26 shares has been set, meaning investors need to invest a minimum of ₹14,820 to participate.
Anthem Biosciences is offering a ₹50 per share discount to its employees. Being a mainboard IPO, the shares will be listed on both BSE and NSE.
The total size of the IPO is ₹3,395 crore, through the sale of 5.96 crore shares. This is a pure offer for sale, meaning no fresh shares will be issued by the company.
Allocation and Grey Market Premium (GMP)
Here’s how the IPO shares are divided:
50% for Qualified Institutional Buyers (QIBs)
15% for Non-Institutional Investors (NIIs)
35% for Retail Investors
According to InvestorsGain, the IPO is currently trading at a ₹86 premium in the grey market.
The highest grey market premium (GMP) recorded so far has been ₹103 per share.
